# Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President’s Emergency Plan for Acquired Immunodeficiency Syndrome Relief - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/fixed-combinations-and-single-entity-versions-of-previously-approved-antiretrovirals-for-the-treatment-or-prevention-of-human-immunodeficiency-virus-one-under-the-presidents-emergency-plan-for-acquired-immunodeficiency-syndrome-relief/a7806ed2-daae-4932-9169-94ac075dfc10

> FDA guidance document: Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President’s Emergency Plan for Acquired Immunodeficiency Syndrome Relief. Issue date: August 01, 2023. Get complete insights and analysis.

---

## Details

- Title: Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President’s Emergency Plan for Acquired Immunodeficiency Syndrome Relief
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-08-01
- Comment Close Date: 2023-11-01
- Last Changed: 2023-08-02
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2004-D-0301">FDA-2004-D-0301</a>

## Related Documents

- [PDUFA Waivers, Reductions, and Refunds for Fixed- Combinations and Single-Entity Versions of Previously Approved Antiretrovirals under PEPFAR](https://www.globalkeysolutions.net/guidances/guidance-document/pdufa-waivers-reductions-and-refunds-for-fixed-combinations-and-single-entity-versions-of-previously-approved-antiretrovirals-under-pepfar/6d0b93d6-4d11-41b1-815d-d6970112dcdd)
- [Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/acute-radiation-syndrome-developing-drugs-for-prevention-and-treatment/a8417155-eb91-45ad-9133-c5685df4fb6d)
- [Dry Eye: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/dry-eye-developing-drugs-for-treatment-guidance-for-industry/c72442af-b5f2-4a62-88b5-4261f9399657)